Brigitte Dréno

Identification of SLC39A4, a gene involved in acrodermatitis enteropathica

Stéphane Bézieau, S. Küry, B. Dréno, 2002, Nature Genetics.

Value of large scale expansion of tumor infiltrating lymphocytes in a compartmentalised gas-permeable bag: interests for adoptive immunotherapy

Bruno Delorme, B. Dréno, J. David, 2011, Journal of Translational Medicine.

European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2019.

Giovanni Pellacani, Josep Malvehy, Axel Hauschild, 2019, European journal of cancer.

Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial.

Matthew Wongchenko, Paolo A Ascierto, Antoni Ribas, 2016, The Lancet. Oncology.

Expression of MAGE genes in primary and metastatic cutaneous melanoma

Rika Deraemaecker, Stefan Suciu, Marie Marchand, 1995, International journal of cancer.

High-scale expansion of melanoma-reactive TIL by a polyclonal stimulus: predictability and relation with disease advancement

Francine Jotereau, B. Dréno, F. Jotereau, 2001, Cancer Immunology, Immunotherapy.

Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study.

Dirk Schadendorf, Alessandro Testori, Axel Hauschild, 2014, The Lancet. Oncology.